Global Enzyme Inhibitors Market 2011-2015

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Enzyme Inhibitors Market 2011-2015

TechNavio's analysts forecast the Global Enzyme Inhibitors market to grow at a CAGR of 4 percent in terms of revenue over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of various diseases. The Global Enzyme Inhibitors market has also been witnessing the trend of an increase in mergers and acquisitions among vendors. However, the patent expiration of enzyme inhibitors across therapeutic categories could pose a challenge to the growth of this market.

TechNavio's research report, the Global Enzyme Inhibitors Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Enzyme Inhibitors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Roche Holding Ltd., AstraZeneca plc, Pfizer Inc., Merck and Co. Inc., and Novartis AG.

Other vendors mentioned in the report are Takeda Pharmaceutical Co. Ltd., Abbott Laboratories Inc., Amgen Inc., Bayer AG, Bristol-Myers Squibb Co., Boehringer Ingelheim GmbH, Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mylan Inc., Johnson and Johnson Ltd., Sanofi S.A., Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Watson Pharmaceuticals Inc.


Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.


01. Executive Summary

02. Introduction

03. Market Coverage

Market Overview

Product Offerings

04. Market Landscape

Market Size

Market Segmentation

04.1 Five Forces Analysis

05. Geographical Segmentation

06. Vendor Landscape

Product Portfolio Matrix

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

13.1 Roche Holding Ltd.

Business Overview

SWOT Analysis

13.2 AstraZeneca plc

Business Overview

SWOT Analysis

13.3 Pfizer Inc.

Business Overview

SWOT Analysis

13.4 Merck and Co. Inc.

Business Overview

SWOT Analysis

13.5 Novartis AG

Business Overview

SWOT Analysis

14. Other Reports in this Series


List of Exhibits:

Exhibit 1: Global Enzyme Inhibitors Market 2011-2015 (US$ billion)

Exhibit 2: Global Enzyme Inhibitors Market Segmentation

Exhibit 3: Global Enzyme Inhibitors Market Segmentation 2011

Exhibit 4: Global Enzyme Inhibitors Market by Geographical Segmentation 2011

Exhibit 5: Global Enzyme Inhibitors Market by Vendor Segmentation 2011


To order this report:

Biopharmaceutical Industry: Global Enzyme Inhibitors Market 2011-2015

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626


SOURCE Reportlinker


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.